H.R. 9679 · 117th Congress

Medical Cannabis Research Act of 2022

Stage
In committee
Sponsor
Matt Gaetz
Introduced
2022-12-22
Latest action
2022-12-22 · Introduced in House

Summary

Medical Cannabis Research Act of 2022

This bill establishes a new, separate registration process for manufacturers of cannabis for research.

As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.

The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.